Rhythm Pharmaceuticals Inc (RYTM) valuation · rev $189.8M
Rhythm Pharmaceuticals Inc (RYTM) rev $189.8M.
| Metric | Value |
|---|---|
| Market cap | $6.49B |
| Revenue | $189.8M |
| P/S | 34.2 |
| P/B | 50.1 |
RYTM valuation FAQ
What is RYTM's market cap?
Rhythm Pharmaceuticals Inc (RYTM) market cap is $6.49B on the latest cached fundamentals snapshot.
What is RYTM's latest revenue?
Latest cached Rhythm Pharmaceuticals Inc (RYTM) revenue was $189.8M. Statements: https://lician.com/financials/rytm
What is RYTM's price-to-sales ratio?
Rhythm Pharmaceuticals Inc (RYTM) price-to-sales (P/S) is 34.2, cached market cap $6.49B divided by revenue $189.8M.
What is RYTM's price-to-book ratio?
Rhythm Pharmaceuticals Inc (RYTM) price-to-book (P/B) is 50.1 on the latest cached fundamentals snapshot.
How many RYTM valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Rhythm Pharmaceuticals Inc (RYTM): Market cap, Revenue, P/S, and P/B.
Where is RYTM valuation listed?
Cached valuation multiples for Rhythm Pharmaceuticals Inc (RYTM) are listed at https://lician.com/valuation/rytm.
Not investment advice. Cached rows, not a live tape.